is farxiga a glp-1 glp 1 How Medicines Work Most GLP-1 medicines up to AZ's GLP-1 Bydureon and SGLT2

Accessed February 2026.

The GLP-1 drug Wegovy for weight issues or obesity is approved for individuals with a BMI of 26-plus and co-morbidities, or those with a BMI of 30-plus

Overall, though, while Farxiga can lead to some weight loss, the effect is generally modest compared to GLP-1s or other weight loss medications

Study: Survival and Recurrence With GLP-1 Receptor Agonists in Breast Cancer

Your body is adjusting to the medication, and the GLP-1 pathway is beginning to reshape hunger signals

Muscle Loss Accelerates A 2024 meta-analysis of nine randomized controlled trials found that roughly **30.8% of weight lost on GLP-1 therapy was lean mass.** Other reviews report figures from 15% to over 40%, depending on the medication, dose, and population studied and newer research suggests some of whats measured as lean mass includes liver and other tissues, not only muscle. The meaningful point isnt the exact number